Found: 18
Select item for more details and to access through your institution.
Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 10, p. 1272, doi. 10.3390/ph17101272
- By:
- Publication type:
- Article
Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 155, doi. 10.3390/cancers15010155
- By:
- Publication type:
- Article
Minimal Residual Disease in Multiple Myeloma: Something Old, Something New.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4332, doi. 10.3390/cancers13174332
- By:
- Publication type:
- Article
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3615, doi. 10.3390/cancers12123615
- By:
- Publication type:
- Article
Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement.
- Published in:
- Clinical Case Reports, 2017, v. 5, n. 8, p. 1258, doi. 10.1002/ccr3.1015
- By:
- Publication type:
- Article
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e844, doi. 10.1016/j.clml.2022.04.024
- By:
- Publication type:
- Article
P-178: Impact of t(11;14) according to induction regimen in newly diagnosed transplant-eligible multiple myeloma patients: long term follow-up of GEM05MENOS65 and GEM2012 PETHEMA/GEM studies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S134, doi. 10.1016/S2152-2650(21)02305-3
- By:
- Publication type:
- Article
OAB-056: A machine learning model based on tumor and immune biomarkers to predict undetectable measurable residual disease (MRD) in transplant-eligible multiple myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S35, doi. 10.1016/S2152-2650(21)02128-5
- By:
- Publication type:
- Article
Management of adverse events (AEs) observed in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma (MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e293, doi. 10.1016/j.clml.2019.09.481
- By:
- Publication type:
- Article
Prognostic implications of MRD assessment in multiple myeloma patients: comparison of Next-Generation Sequencing and Next-Generation Flow.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e47, doi. 10.1016/j.clml.2019.09.071
- By:
- Publication type:
- Article
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00652-2
- By:
- Publication type:
- Article
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00490-8
- By:
- Publication type:
- Article
Increasing therapy‐related myeloid neoplasms in multiple myeloma.
- Published in:
- European Journal of Clinical Investigation, 2019, v. 49, n. 2, p. N.PAG, doi. 10.1111/eci.13050
- By:
- Publication type:
- Article
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203392
- By:
- Publication type:
- Article